MicroPort CardioFlow Medtech Corp
Company Profile
Business description
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China. The Group derives revenue from the sales of medical devices through appointed distributors. It derives maximum revenue from PRC.
Contact
No. 1601 Zhangdong Road
Zhangjiang Hi-Tech Park
Pudong New District
Shanghai201203
CHNT: +86 2138954600
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
417
Stocks News & Analysis
stocks
Meta earnings: Strong end to 2025 as AI monetization begins to show
stocks
Why doesn’t the market like the earnings from this US tech giant?
stocks
Our Tesla fair value increases meaningfully
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,157.60 | 101.60 | -1.10% |
| CAC 40 | 8,071.36 | 4.68 | 0.06% |
| DAX 40 | 24,309.46 | 513.33 | -2.07% |
| Dow JONES (US) | 49,071.56 | 55.96 | 0.11% |
| FTSE 100 | 10,171.76 | 17.33 | 0.17% |
| HKSE | 27,469.82 | 498.27 | -1.78% |
| NASDAQ | 23,685.12 | 172.33 | -0.72% |
| Nikkei 225 | 53,326.17 | 49.43 | -0.09% |
| NZX 50 Index | 13,423.18 | 74.57 | 0.56% |
| S&P 500 | 6,969.01 | 9.02 | -0.13% |
| S&P/ASX 200 | 8,863.10 | 92.00 | -1.03% |
| SSE Composite Index | 4,108.46 | 49.52 | -1.19% |